283 related articles for article (PubMed ID: 31767634)
1. Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover.
Liu G; Byrd A; Warner AN; Pei F; Basha E; Buchanan A; Buchan JR
Mol Cell Biol; 2020 Jan; 40(4):. PubMed ID: 31767634
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.
Sun Z; Diaz Z; Fang X; Hart MP; Chesi A; Shorter J; Gitler AD
PLoS Biol; 2011 Apr; 9(4):e1000614. PubMed ID: 21541367
[TBL] [Abstract][Full Text] [Related]
3. Endocytosis regulates TDP-43 toxicity and turnover.
Liu G; Coyne AN; Pei F; Vaughan S; Chaung M; Zarnescu DC; Buchan JR
Nat Commun; 2017 Dec; 8(1):2092. PubMed ID: 29233983
[TBL] [Abstract][Full Text] [Related]
4. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
Ito D; Suzuki N
Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
[TBL] [Abstract][Full Text] [Related]
5. FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis.
Kryndushkin D; Wickner RB; Shewmaker F
Protein Cell; 2011 Mar; 2(3):223-36. PubMed ID: 21452073
[TBL] [Abstract][Full Text] [Related]
6. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
7. TDP-43/FUS in motor neuron disease: Complexity and challenges.
Guerrero EN; Wang H; Mitra J; Hegde PM; Stowell SE; Liachko NF; Kraemer BC; Garruto RM; Rao KS; Hegde ML
Prog Neurobiol; 2016; 145-146():78-97. PubMed ID: 27693252
[TBL] [Abstract][Full Text] [Related]
8. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
[TBL] [Abstract][Full Text] [Related]
9. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration.
Zhao B; Cowan CM; Coutts JA; Christy DD; Saraph A; Hsueh SCC; Plotkin SS; Mackenzie IR; Kaplan JM; Cashman NR
Acta Neuropathol Commun; 2023 Dec; 11(1):200. PubMed ID: 38111057
[TBL] [Abstract][Full Text] [Related]
10. Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis.
De Marco G; Lomartire A; Manera U; Canosa A; Grassano M; Casale F; Fuda G; Salamone P; Rinaudo MT; Colombatto S; Moglia C; Chiò A; Calvo A
Sci Rep; 2022 Jan; 12(1):395. PubMed ID: 35013445
[TBL] [Abstract][Full Text] [Related]
11. "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis.
Aksoy YA; Deng W; Stoddart J; Chung R; Guillemin G; Cole NJ; Neely GG; Hesselson D
Int J Biochem Cell Biol; 2020 Sep; 126():105821. PubMed ID: 32758633
[TBL] [Abstract][Full Text] [Related]
12. Characteristic Features of FUS Inclusions in Spinal Motor Neurons of Sporadic Amyotrophic Lateral Sclerosis.
Ikenaka K; Ishigaki S; Iguchi Y; Kawai K; Fujioka Y; Yokoi S; Abdelhamid RF; Nagano S; Mochizuki H; Katsuno M; Sobue G
J Neuropathol Exp Neurol; 2020 Apr; 79(4):370-377. PubMed ID: 32142134
[TBL] [Abstract][Full Text] [Related]
13. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
[TBL] [Abstract][Full Text] [Related]
14. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
Wächter N; Storch A; Hermann A
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
[TBL] [Abstract][Full Text] [Related]
15. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis.
Tyzack GE; Luisier R; Taha DM; Neeves J; Modic M; Mitchell JS; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
Brain; 2019 Sep; 142(9):2572-2580. PubMed ID: 31368485
[TBL] [Abstract][Full Text] [Related]
16. [Conjoint pathological cascades mediated by RNA-binding proteins, TDP-43, FUS and ataxin-2].
Ito D
Rinsho Shinkeigaku; 2012; 52(11):1221-3. PubMed ID: 23196570
[TBL] [Abstract][Full Text] [Related]
17. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
Strong MJ; Volkening K
FEBS J; 2011 Oct; 278(19):3569-77. PubMed ID: 21810174
[TBL] [Abstract][Full Text] [Related]
18. Valosin-containing protein regulates the stability of fused in sarcoma granules in cells by changing ATP concentrations.
Yasuda K; Watanabe TM; Kang MG; Seo JK; Rhee HW; Tate SI
FEBS Lett; 2022 Jun; 596(11):1412-1423. PubMed ID: 35445401
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral expression of TDP-43 and FUS genes and shRNAs for protein degradation pathways in rodent motoneurons in vitro and in vivo.
Watabe K; Akiyama K; Kawakami E; Ishii T; Endo K; Yanagisawa H; Sango K; Tsukamoto M
Neuropathology; 2014 Feb; 34(1):83-98. PubMed ID: 23937386
[TBL] [Abstract][Full Text] [Related]
20. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.
Daigle JG; Krishnamurthy K; Ramesh N; Casci I; Monaghan J; McAvoy K; Godfrey EW; Daniel DC; Johnson EM; Monahan Z; Shewmaker F; Pasinelli P; Pandey UB
Acta Neuropathol; 2016 Apr; 131(4):605-20. PubMed ID: 26728149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
